Global Human Milk Oligosaccharides Market – Trends & Forecast, 2019-2025

Detailed TOC of Global Human Milk Oligosaccharides Market – Trends & Forecast, 2019-2025

Table of Contents:

1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising Application in Functional Foods
4.2.2 Increasing Demand in Infant Formula
4.2.3 Growing Participation by Market Players
4.3 Restraint
4.3.1 High Production Costs
4.4 Opportunity
4.4.1 Expansion in Emerging Economies
5 Market Factor Analysis
5.1 Porter's 5 Forces Analysis
5.1.1 Threat of New Entrants
5.1.2 Bargaining Power of Suppliers
5.1.3 Threat of Substitutes
5.1.4 Bargaining Power of Buyers
5.1.5 Rivalry
6 Global Human Milk Oligosaccharides Market, By Type
6.1 Overview
6.2 Neutral
6.3 Acidic
7 Global Human Milk Oligosaccharides Market, by Application
7.1 Overview
7.2 Food Industry
7.3 Laboratory Research
8 Global Human Milk Oligosaccharides Market, by Region/Country
8.1 Overview
8.2 North America
8.3 Europe
8.4 China
8.5 Japan
9 Competitive Landscape
9.1 Overview
9.2 Competitive Benchmarking
9.3 Leading Player in terms of Number of Developments in Human Milk Oligosaccharides Market
9.4 Key Development Analysis
9.4.1 Product Launch
9.4.2 Regulatory Approval
9.4.3 Merger & Acquisition
9.4.4 Expansion
9.4.5 Joint Venture
10 Company Profiles
10.1 Abbott
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategies
10.2 BASF SE
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategies
10.3 Dextra Laboratories Limited
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategies
10.4 DuPont Nutrition & Health
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategies
10.5 Elicityl S.A.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategies
10.6 Glycom
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products Offering
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategies
10.7 Glycosyn LLC
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategies
10.8 Inbiose
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategies
10.9 Jennewein Biotechnologie GmbH
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products Offering
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategies
10.1 Medolac Laboratories
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategies
10.11 Nestlé Health Science
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Products/Services Offered
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.11.6 Key Strategies
10.12 ZuChem
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Products/Services Offered
10.12.4 Key Developments
10.12.5 SWOT Analysis
10.12.6 Key Strategies
11 Appendix
11.1 References
11.2 Related Reports